Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» PAH
PAH
Actelion’s Lung Drug May Face Study Against Gilead Rival
Bloomberg
Wed, 02/12/14 - 09:50 am
Actelion
Gilead Sciences
Opsumit
Letairis
PAH
pulmonary arterial hypertension
Actelion gets second boost for Opsumit with EU approval
Fierce Pharma
Mon, 12/23/13 - 03:23 pm
Actelion
Opsumit
Europe
Tracleer
PAH
pulmonary arterial hypertension
United Therapeutics Shares Gain on FDA Hypertension Approval
Bloomberg
Mon, 12/23/13 - 11:27 am
FDA
United Therapeutics
PAH
pulmonary arterial hypertension
Did One Of The Top 10 Upside Surprises In The History Of The Biotech Sector Just Happen?
Forbes
Mon, 12/23/13 - 10:22 am
Remodulin
PAH
pulmonary arterial hypertension
Orenitram
United Therapeutics
United Therapeutics receives subpoena for 3 drugs
Yahoo/AP
Mon, 12/9/13 - 10:09 am
United Therapeutics
PAH
Remodulin
Tyvaso
Adcirca
pulmonary arterial hypertension
Actelion hits 6-yr high after favourable FDA approval for drug
Yahoo/Reuters
Mon, 10/21/13 - 08:36 am
FDA
Actelion
Opsumit
PAH
Actelion Wins U.S. FDA Approval for Lung Disorder Therapy
Bloomberg
Fri, 10/18/13 - 05:47 pm
Actelion
FDA
Opsumit
PAH
Patient in Arena lung drug trial experiences heart problem
Reuters
Thu, 08/29/13 - 10:27 am
Arena Pharmaceuticals
APD811
PAH
pulmonary arterial hypertension
Arena Pharmaceuticals' candidate for pulmonary hypertension completes Phase 1b
Yahoo/Fly on the Wall
Wed, 08/28/13 - 10:45 am
PAH
pulmonary arterial hypertension
Arena Pharmaceuticals
APD811
United Therapeutics' Second PAH Stumble Emphasizes The Need For Pluristem's Therapy
Seeking Alpha
Tue, 04/30/13 - 08:37 am
United Therapeutics
PAH
pulmonary arterial hypertension
Remodulin
Pluristem Therapeutics
Actelion Looks Within as Competition Lifts Drug Prices
Bloomberg
Mon, 02/18/13 - 12:24 pm
Actelion
pulmonary arterial hypertension
PAH
Tracleer
Bayer Seeks Riociguat Approval
Yahoo/Zacks
Wed, 02/13/13 - 10:22 am
Bayer
Riociguat
PAH
pulmonary arterial hypertension
Watson to sell generic version of Pfizer's Revatio
Yahoo/AP
Mon, 11/12/12 - 12:25 pm
Pfizer
generics
Watson Pharmaceuticals
Revatio
pulmonary arterial hypertension
PAH
Detailed data supports Actelion's big lung drug hope
Reuters
Wed, 10/24/12 - 12:05 pm
Actelion
macitentan
PAH
United Therapeutics Falls as FDA Rejects Oral Remodulin
Bloomberg
Wed, 10/24/12 - 11:43 am
FDA
Remodulin
United Therapeutics
PAH
Bayer lung drug shows promise in pulmonary hypertension
Reuters
Mon, 10/22/12 - 12:09 pm
Bayer
PAH
Actelion
Gilead
Riociguat
Tracleer
United Therapeutics Could Lose The Battle For PAH Therapies
TheStreet.com
Mon, 10/22/12 - 10:57 am
United Therapeutics
PAH
Remodulin
Tyvaso
Adcirca
FDA warns against use of Pfizer's Revatio in children
Reuters
Fri, 08/31/12 - 12:20 pm
FDA
Pfizer
Revatio
PAH
pulmonary arterial hypertension
Actelion Lung Drug Meets Main Goal in Pivotal Study
Bloomberg
Mon, 04/30/12 - 10:21 am
Actelion
macitentan
pulmonary arterial hypertension
PAH
United Therapeutics shares tumble on clinical trial failure
Bizjournals.com
Wed, 08/24/11 - 09:19 am
United Therapeutics
PAH
treprostinil diethanolamine
Pages
« first
‹ previous
1
2
3
4
5
next ›
last »